Finance

Lists
HRTIS:HEL
Herantis Pharma Oyj
1,36 €
+1,19%
(+0,016) 1D
14 қаз., 13:50:49 GMT+3  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HRTIS...
Open
1,36 €
High
1,37 €
Low
1,35 €
Mkt. cap
36,15 млн
Avg. vol.
24,79 мың
Volume
3,91 мың
52-wk high
2,87 €
52-wk low
1,32 €
EPS
-0,28 €
Shares outstanding
26,50 млн
No. of employees
14
Open
1,36 €
High
1,37 €
Low
1,35 €
Mkt. cap
36,15 млн
Avg. vol.
24,79 мың
Volume
3,91 мың
52-wk high
2,87 €
52-wk low
1,32 €
EPS
-0,28 €
Shares outstanding
26,50 млн
No. of employees
14
News stories
From web sources and news partners
About Herantis Pharma Oyj
CEOAntti Vuolanto
Employees14
Founded2008
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402,99 м.
402,99 м.
585,00 м.
585,00 м.
Operating expense
1,72 млн
1,72 млн
1,53 млн
1,53 млн
Total operating expenses
1,72 млн
1,72 млн
1,53 млн
1,53 млн
Operating income
-1,72 млн
-1,72 млн
-1,53 млн
-1,53 млн
Other non operating income
-150,07 м.
-150,07 м.
15,00 мың
15,00 мың
EBT including unusual items
-1,71 млн
-1,71 млн
-1,66 млн
-1,66 млн
EBT excluding unusual items
-1,71 млн
-1,71 млн
-1,66 млн
-1,66 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
1,32 млн
1,32 млн
946,50 м.
946,50 м.
Net income
-1,71 млн
-1,71 млн
-1,66 млн
-1,66 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
160,84 м.
160,84 м.
3,50 мың
3,50 мың
Interest expense
-
-
-149,00 м.
-149,00 м.
Net interest expenses
160,84 м.
160,84 м.
-145,50 м.
-145,50 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары